Acquisitions (Detail Textuals 1) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Business Acquisition [Line Items]
Upfront payment	$ 46,576	$ 10,377
Contingent liability	9,172	7,266
Acquisition related compensation expense	$ 1,680	$ 747
Technology-related assets
Business Acquisition [Line Items]
Identifiable intangible assets useful life	13 years
Collaboration and Distribution Agreement (the "Collaboration Agreement") | MJ Biologics, Inc. ("MJB")
Business Acquisition [Line Items]
Intangible assets	$ 9,156
In-process research and development	1,579
Closing payment on pro rated on monthly basis	$ 5,040
Identifiable intangible assets useful life	15 years
Acquisition related compensation expense	$ 1,680
Collaboration and Distribution Agreement (the "Collaboration Agreement") | MJ Biologics, Inc. ("MJB") | Technology-related assets
Business Acquisition [Line Items]
Intangible assets	7,577
Collaboration and Distribution Agreement (the "Collaboration Agreement") | MJ Biologics, Inc. ("MJB") | Long-term liability
Business Acquisition [Line Items]
Long-term liability net of upfront payment	4,156
Purchase Agreement | MJ Biologics, Inc. ("MJB")
Business Acquisition [Line Items]
Upfront payment	5,000
Minimum closing payment	10,000
Contingent liability	$ 1,476